• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄与前列腺特异性抗原检测可能性之间的非线性关系,以及不同年龄进行检测的预测因素。

Nonlinear Relationship Between Age and Likelihood of Undergoing Prostate-Specific Antigen Testing, and the Predictive Factors of Testing at Different Ages.

机构信息

Clinical Research Center, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China.

School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, People's Republic of China.

出版信息

Am J Mens Health. 2021 May-Jun;15(3):15579883211026515. doi: 10.1177/15579883211026515.

DOI:10.1177/15579883211026515
PMID:34167355
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8246524/
Abstract

OBJECTIVE

To investigate the nonlinear relationship between age and the likelihood of undergoing prostate-specific antigen (PSA) testing, and the difference of factors influencing the test likelihood among subjects aged 40-54, 55-69, and ≥70 years.

METHODS

Data were extracted from the 2018 Behavioral Risk Factor Surveillance System, with the primary outcome defined as receipt of a PSA test within the previous 12 months. Restricted cubic splines were used to assess the relationship between age and the likelihood of undergoing PSA testing. Backward conditional logistic regression analyses were used to identify the predictors of undergoing PSA testing among subjects aged 40-54, 55-69, and ≥70 years.

RESULTS

Finally, 92,177 people were identified. The likelihood of PSA testing increased up to around 71 years old and then decreased rapidly for higher ages, showing a clear nonlinear inverted U-shaped relationship with age ( < .001). Insurance status, shared decision-making, whether a recommendation for PSA testing had been accepted, income level, smoking status, and age were the common predictors of testing in the three age groups. However, the predictors differed somewhat among the three groups: being overweight or obese was only positively associated with increased testing among people aged 40-54 and ≥70 years, being retired only greatly impacted the test likelihood among those aged 40-54 years, and the general health status, marital status, and race affected people aged ≥55 years.

CONCLUSION

The factors influencing PSA screening differ with age, which should be fully considered when screening different target age groups.

摘要

目的

探讨年龄与前列腺特异性抗原(PSA)检测可能性之间的非线性关系,以及 40-54 岁、55-69 岁和≥70 岁人群中影响检测可能性的因素差异。

方法

从 2018 年行为风险因素监测系统中提取数据,主要结局定义为在过去 12 个月内接受 PSA 检测。使用限制三次样条评估年龄与接受 PSA 检测可能性之间的关系。使用向后条件逻辑回归分析确定 40-54 岁、55-69 岁和≥70 岁人群中进行 PSA 检测的预测因素。

结果

最终纳入 92177 人。PSA 检测的可能性在 71 岁左右之前增加,然后随着年龄的增长迅速下降,与年龄之间呈现出明显的非线性倒 U 型关系(<0.001)。保险状况、共同决策、是否接受 PSA 检测建议、收入水平、吸烟状况和年龄是三个年龄组检测的共同预测因素。然而,预测因素在三个组之间存在一定差异:超重或肥胖仅与 40-54 岁和≥70 岁人群的检测增加呈正相关,退休仅对 40-54 岁人群的检测可能性有重大影响,一般健康状况、婚姻状况和种族影响≥55 岁人群。

结论

影响 PSA 筛查的因素随年龄而变化,在筛查不同目标年龄组时应充分考虑这些因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8246524/3f2d9423908c/10.1177_15579883211026515-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8246524/f6ebbbf77254/10.1177_15579883211026515-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8246524/d59637ecb754/10.1177_15579883211026515-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8246524/d4af48cb69e6/10.1177_15579883211026515-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8246524/3f2d9423908c/10.1177_15579883211026515-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8246524/f6ebbbf77254/10.1177_15579883211026515-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8246524/d59637ecb754/10.1177_15579883211026515-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8246524/d4af48cb69e6/10.1177_15579883211026515-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20c2/8246524/3f2d9423908c/10.1177_15579883211026515-fig4.jpg

相似文献

1
Nonlinear Relationship Between Age and Likelihood of Undergoing Prostate-Specific Antigen Testing, and the Predictive Factors of Testing at Different Ages.年龄与前列腺特异性抗原检测可能性之间的非线性关系,以及不同年龄进行检测的预测因素。
Am J Mens Health. 2021 May-Jun;15(3):15579883211026515. doi: 10.1177/15579883211026515.
2
Disparities Associated with Shared Decision-making in Prostate Cancer Screening.前列腺癌筛查中与共同决策相关的差异。
Eur Urol Focus. 2023 Nov;9(6):1008-1015. doi: 10.1016/j.euf.2023.04.013. Epub 2023 May 15.
3
Impact of health literacy on shared decision making for prostate-specific antigen screening in the United States.健康素养对美国前列腺特异性抗原筛查中共同决策的影响。
Cancer. 2021 Jan 15;127(2):249-256. doi: 10.1002/cncr.33239. Epub 2020 Nov 9.
4
Demographics and health-related factors of men receiving prostate-specific antigen screening in Utah.犹他州接受前列腺特异性抗原筛查男性的人口统计学和健康相关因素。
Prev Med. 2001 Dec;33(6):646-52. doi: 10.1006/pmed.2001.0940.
5
Pre-screening Discussions and Prostate-Specific Antigen Testing for Prostate Cancer Screening.前列腺癌筛查的预筛查讨论及前列腺特异性抗原检测
Am J Prev Med. 2015 Aug;49(2):259-63. doi: 10.1016/j.amepre.2015.02.007. Epub 2015 May 18.
6
Prostate-specific antigen testing rates in high-risk populations: results from the All of Us Research Program.高危人群中前列腺特异性抗原检测率:来自“我们所有人”研究项目的结果。
Cancer Causes Control. 2024 Mar;35(3):509-521. doi: 10.1007/s10552-023-01807-7. Epub 2023 Oct 25.
7
The Impact of Receipt of Information on Prostate-Specific Antigen Testing on Screening with the Prostate-Specific Antigen Test.接受信息对前列腺特异性抗原检测用于前列腺特异性抗原检测筛查的影响。
J Cancer Educ. 2023 Aug;38(4):1313-1321. doi: 10.1007/s13187-023-02264-1. Epub 2023 Jan 18.
8
Factors influencing primary care physicians' decision to order prostate-specific antigen (PSA) test for men without prostate cancer.影响初级保健医生决定为无前列腺癌男性开具前列腺特异性抗原(PSA)检测的因素。
Acta Oncol. 2013 Nov;52(8):1602-8. doi: 10.3109/0284186X.2012.762998. Epub 2013 Feb 19.
9
Examination of prostate-specific antigen (PSA) screening in military and civilian men: analysis of the 2018 behavioral risk factor surveillance system.前列腺特异性抗原(PSA)筛查在军人和普通男性中的应用:2018 年行为风险因素监测系统分析。
Cancer Causes Control. 2022 Mar;33(3):393-402. doi: 10.1007/s10552-021-01533-y. Epub 2022 Jan 16.
10
Does Veteran Status Mitigate Racial Disparities in Prostate Cancer Screening? Analysis of Prostate Specific Antigen Screening Patterns in the 2018 Behavioral Risk Factor Surveillance System Data.退伍军人身份是否能减轻前列腺癌筛查中的种族差异?2018 年行为风险因素监测系统数据中前列腺特异性抗原筛查模式的分析。
J Urol. 2022 May;207(5):993-1000. doi: 10.1097/JU.0000000000002379. Epub 2021 Dec 30.

引用本文的文献

1
Effect of smoking on prostate cancer: Results from the National Health and Nutrition Examination Survey 2003-2018 and Mendelian randomization analyses.吸烟对前列腺癌的影响:2003 - 2018年美国国家健康和营养检查调查及孟德尔随机化分析结果
Tob Induc Dis. 2024 Jun 4;22. doi: 10.18332/tid/189199. eCollection 2024.
2
Prostate-specific antigen testing rates in high-risk populations: results from the All of Us Research Program.高危人群中前列腺特异性抗原检测率:来自“我们所有人”研究项目的结果。
Cancer Causes Control. 2024 Mar;35(3):509-521. doi: 10.1007/s10552-023-01807-7. Epub 2023 Oct 25.

本文引用的文献

1
Impact of health literacy on shared decision making for prostate-specific antigen screening in the United States.健康素养对美国前列腺特异性抗原筛查中共同决策的影响。
Cancer. 2021 Jan 15;127(2):249-256. doi: 10.1002/cncr.33239. Epub 2020 Nov 9.
2
Racial and Ethnic Variation in PSA Testing and Prostate Cancer Incidence Following the 2012 USPSTF Recommendation.2012 年美国预防服务工作组建议发布后,PSA 检测和前列腺癌发病率的种族和民族差异。
J Natl Cancer Inst. 2021 Jun 1;113(6):719-726. doi: 10.1093/jnci/djaa171.
3
Cancer statistics, 2020.癌症统计数据,2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
4
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study.全球、区域和国家癌症发病率、死亡率、生命损失年数、失能生存年数以及 29 种癌症组别的伤残调整生命年数:1990 至 2017 年全球疾病负担研究的系统分析。
JAMA Oncol. 2019 Dec 1;5(12):1749-1768. doi: 10.1001/jamaoncol.2019.2996.
5
Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates.近期全球前列腺癌发病率和死亡率模式。
Eur Urol. 2020 Jan;77(1):38-52. doi: 10.1016/j.eururo.2019.08.005. Epub 2019 Sep 5.
6
Are Men Making Informed Decisions According to the Prostate-Specific Antigen Test Guidelines? Analysis of the 2015 Behavioral Risk Factor Surveillance System.男性是否根据前列腺特异性抗原检测指南做出知情决策?2015 年行为风险因素监测系统分析。
Am J Mens Health. 2019 Mar-Apr;13(2):1557988319834843. doi: 10.1177/1557988319834843.
7
Screening for Prostate Cancer.前列腺癌筛查
JAMA. 2018 May 8;319(18):1946. doi: 10.1001/jama.2018.4972.
8
Annual Report to the Nation on the Status of Cancer, part II: Recent changes in prostate cancer trends and disease characteristics.国家癌症报告:第二部分:前列腺癌趋势和疾病特征的最新变化。
Cancer. 2018 Jul 1;124(13):2801-2814. doi: 10.1002/cncr.31549. Epub 2018 May 22.
9
The Epidemiology of Prostate Cancer.前列腺癌的流行病学。
Cold Spring Harb Perspect Med. 2018 Dec 3;8(12):a030361. doi: 10.1101/cshperspect.a030361.
10
Prostate Cancer Screening in Early Medicaid Expansion States.早期医疗补助扩大州的前列腺癌筛查
J Urol. 2018 Jan;199(1):81-88. doi: 10.1016/j.juro.2017.07.083. Epub 2017 Jul 29.